JoVE Biology

Ole Isacson: Development of New Therapies for Parkinson's Disease

1

1McLean Hospital, Harvard Stem Cell Institute, Harvard Medical School

Article
    Downloads Comments Metrics Publish with JoVE

    You must be subscribed to JoVE to access this content.

    Enter your email to receive a free trial:

    Welcome!

    Enter your email below to get your free 10 minute trial to JoVE!


    Admit it, you like to watch.

     

    Summary

    Ole Isacson gives a concise overview of Parkinsons's disease, its causes, therapeutic strategies, and advances in Parkinson's research.

    Date Published: 4/29/2007, Issue 3; doi: 10.3791/189

    Cite this Article

    Isacson, O. Ole Isacson: Development of New Therapies for Parkinson's Disease. J. Vis. Exp. (3), e189, doi:10.3791/189 (2007).

    Disclosures

    References

    1. Chung, C. Y., Seo, H., Sonntag, K. C., Brooks, A., Lin, L., Iasacson, O. Cell type specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability. Hum. Mol. Genet. 14, 1709-1725 (2005).
    2. Mendez, I., Sanchez-Pernaute, R., Cooper, O., Vinuela, A., Ferrari, D., Bjoerklund, L., Dagher, A., Isacson, O. Cell type analysis of fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain. 128, (7), 1498-1510 (2005).
    3. Cooper, O., Isacson, O. Intrastiatal Transforming Growth Factor Delivery to a Model of Parkinson's Disease Induces Proliferation and Migration of Endogenous Adult Neural Progenitor Cells without Differentiation into Dopaminergic Neurons. J. Neurosci. 24, (41), 8924-8931 (2004).
    4. Sanchez-Pernaute, R., Ferree, A., Cooper, O., Yu, M., Brownell, A. L., Isacson, O. Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat mod of Parkinson's disease. Journal of Neuroinflammation. (2004).
    5. Isacson, O. The production and use of cells as therapeutic agents in neurodegenerative diseases. Lancet Neurology. 2, (7), 417-424 (2003).

    Comments

    5 Comments

    nice
    Reply

    Posted by: AnonymousJuly 22, 2009, 3:13 AM

    i know you want to see my comment "very interesting" so here it is : very interesting
    Reply

    Posted by: AnonymousOctober 14, 2009, 5:04 PM

    Post a Question / Comment / Request

    You must be signed in to post a comment. Please or create an account.

    Metrics

    Waiting
    simple hit counter